St. Jude Medical (STJ) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts STJ Hot Sheet
Price: $80.82 --0%
Financial Fact:
Cash dividends declared per share:: 0.31
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Cash dividends declared per share:: 0.31
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
St. Jude Medical (NYSE: STJ) reported Q2 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $1.56 billion versus the consensus estimate of $1.55 billion.
Third Quarter and Full-Year 2016 Sales and Earnings Guidance
Due to the planned merger with Abbott, St. Jude Medical is withdrawing financial guidance for the fiscal year 2016.
For earnings history and earnings-related data on St. Jude Medical (STJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Chime to acquire Stride Bank for $590M in cash
- Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
